Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for September 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Two new AstraZeneca laboratories opened in UK
Biggest ever single investment..(more)

 Three innovative medicines win Prix Galien awards
GSK, Roche and Genzyme all honoured..(more)

 UCB to buy Schwarz Pharma for 4 billion euros
European pharma merger is third in five days..(more)

 GSK gambles on success of new European pricing deal
Deal struck with two EU countries..(more)

 Noxafil close to approval for invasive fungal infections
Schering-Plough's drug set to expand reach..(more)

 Integrated Huntsworth Health moves into top tier
Advertising, PR and med ed brought together..(more)

 AZ and Schering take novel approach in cancer collaboration
Companies split development into clinical and non-clinical work..(more)

 Merck to buy Serono for $13 billion
Long search for buyer ends..(more)

 Gardasil approved in Europe
First ever vaccine against cervical cancer..(more)

 Specialist pharma company Nycomed buys Altana
Merger will forge new Danish-German middleweight..(more)

 New diabetes drug Byetta set for European approval
First in class drug helps patients lose weight..(more)

 Lipitor patients sue Pfizer
Company accused of failing to warn of drug's side-effects..(more)

 NHS preparing to cut A&E and maternity units
Plans aim to improve patient care by establishing specialist units..(more)

 Dolan forced out over Plavix affair
BMS executives could face criminal charges..(more)

 DHL deal 'catastrophic' for UK medical devices industry
ABHI says government's NHS policy could lead to bankruptcies for smaller companies..(more)

 PCTs to retain clinical leadership role
Hopes that PECs will bring stability to the NHS' period of change ..(more)

 New PCTs to tighten general practice prescribing controls
Doctors to become more accountable for drug spending..(more)

 Public affairs agency Advocate launched
Agency's aim is to demystify health policies for clients..(more)

 NICE takes aim at ineffective treatments
Money saved will be reinvested in new medicines and clinical procedures..(more)

 Collaboration to develop new Parkinson's Disease dyskinesia treatment
Drug will benefit 20% of PD patients suffering from levodopa side-effect..(more)

 NicOx to develop enhanced statin product
Company says its new technology has transformed drug's efficacy..(more)

 Generic Plavix challenge hits BMS and Sanofi forecasts
Apotex's generic floods market despite US court injunction banning sales..(more)

 Cannabis-derived MS treatment filed in Europe
GW Pharmaceuticals submits new trial data for Sativex..(more)

 NHS 'sell off' angers unions
UNISON to ballot members over government's supplies deal with DHL ..(more)

 One in four older patients missing out on medicines
Survey highlights gaps in patient-compliance in the elderly..(more)

 AstraZeneca and charity spin-off collaborate on colorectal cancer research
Collaboration aims to develop novel treatments for chemo-resistant tumours..(more)

 Think-tank calls for new cancer strategy
King's Fund says cancer plan must anticipate future challenges..(more)

 GSK signs $1.5 billion drug discovery deal
ChemoCentryx partnership gives GSK access to innovative biotech products..(more)

 EU approval for Novartis' Exjade
Breakthrough oral drug set to replace infusional Desferal..(more)

 NICE to fast-track more drugs
Government attempts to end 'NICE blight'..(more)

 UK pharma suffering an 'exodus' of new talent
Fears that long-term effect could be a serious skills shortage..(more)

 NICE called on to lead the fight against obesity
Instittute to produce strategies and guidance to improve public health..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.